Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

EGFL7 Antikörper (C-Term)

EGFL7 Reaktivität: Human WB, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN1589899
  • Target Alle EGFL7 Antikörper anzeigen
    EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
    Bindungsspezifität
    • 4
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reaktivität
    • 31
    • 7
    • 4
    Human
    Wirt
    • 23
    • 8
    • 1
    • 1
    • 1
    Kaninchen
    Klonalität
    • 27
    • 7
    Polyklonal
    Konjugat
    • 23
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser EGFL7 Antikörper ist unkonjugiert
    Applikation
    • 20
    • 16
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    Western Blotting (WB), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Verwendungszweck
    VE-Statin/EGFL7 antibody
    Spezifität
    Recombinant human EGFL-7 C-Terminus
    Produktmerkmale
    Chromosomal location: 9q34.3
    Produced from sera of rabbits immunised with highly pure recombinant human VE-Statin/EGFL-7.
    Aufreinigung
    Anti-human VE-Statin/EGFL-7 was purified by Protein-A chromatography.
    Immunogen
    Recombinant human EGFL7 C-Terminus
    Isotyp
    IgG
    Top Product
    Discover our top product EGFL7 Primärantikörper
  • Applikationshinweise
    Western Blot: Use 2-5 μg/mL
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.
    Buffer
    PBS
    Handhabung
    Centrifuge vial prior to opening.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.
    Haltbarkeit
    24 months
  • Target
    EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
    Andere Bezeichnung
    VE-Statin/EGFL7 (EGFL7 Produkte)
    Synonyme
    egfl7 antikoerper, MGC53105 antikoerper, EGFL7 antikoerper, zgc:136669 antikoerper, zgc:152804 antikoerper, zneu1 antikoerper, xegfl7 antikoerper, MGC147423 antikoerper, VE-statin antikoerper, Zneu1 antikoerper, NEU1 antikoerper, RP11-251M1.2 antikoerper, VE-STATIN antikoerper, ZNEU1 antikoerper, EGF like domain multiple 7 S homeolog antikoerper, EGF like domain multiple 7 antikoerper, EGF-like-domain, multiple 7 antikoerper, EGF-like domain 7 antikoerper, egfl7.S antikoerper, EGFL7 antikoerper, egfl7 antikoerper, Egfl7 antikoerper
    Hintergrund
    EGFL7, NEU1, ZNEU1, VE-STATIN, RP11-251M1.2, NOTCH4-like protein, Vascular endothelial statin,EGFL7 (VE-Statin) is an ~ 30 kDa secreted protein that contains an Emilin-like (EMI) domain (a multimerization motif), and two epidermal growth factor (EGF) domains, one of which binds calcium. Based on these domains, it has been hypothesized that EGFL7 may self-assemble like extracellular matrix (ECM) proteins and, thus, could incorporate into ECM. EGFL7 has been reported to stimulate cell adhesion as well as motility in a manner similar to ECM proteins. EGFL7 has been shown to be primarily expressed by developing ECs but also by primordial germ cells and some central nervous system neurons. Interestingly, EGFL7 expression markedly decreases in ECs in postnatal life, but can be strongly up-regulated after various tissue injuries that lead to increased angiogenic responses.
    Gen-ID
    51164
    NCBI Accession
    NM_016215, NP_057299
    UniProt
    Q9UHF1
Sie sind hier:
Kundenservice